TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - AMGEN TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - AMGEN Share Price
Certificat
DE000SF7VWH2
| Market Closed - Deutsche Boerse AG 01:12:03 15/06/2024 am IST | ||
| 11.48 EUR | -0.35% |
|
| Current month | -4.65% | ||
| 1 month | -9.61% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 14/24/14 | 11.48 | -0.35% |
| 13/24/13 | 11.52 | -0.95% |
| 12/24/12 | 11.63 | -0.68% |
| 11/24/11 | 11.71 | -2.34% |
| 10/24/10 | 11.99 | -0.66% |
Delayed Quote Deutsche Boerse AG
Last update June 15, 2024 at 01:12 am IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SF7VWH |
| ISIN | DE000SF7VWH2 |
| Date issued | 23/08/2021 |
| Strike | 176.7 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 6.26 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.41 € |
|---|---|
| Lowest since issue | 4.14 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
298.6
USD
Average target price
316.4
USD
Spread / Average Target
+5.97%
- Stock Market
- Certificates
- Certificat
